Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair

Sponsor
Isfahan University of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT02752308
Collaborator
(none)
60
2
5.9

Study Details

Study Description

Brief Summary

From September 2014 to March 2015, 57 consecutive patients with hypospadias who are candidate for surgery will be enrolled in this randomized clinical trial.

Regional ethics committee of Isfahan University of Medical Sciences approved the protocol of the study and all parents will sign a written informed consent.

Inclusion criteria are age between 6 months to 15 years and hypospadias with any severity. Exclusion criteria are coagulopathy, history of previous failed surgery, skin infection , parents' disagreement with the protocol and any cardiac problem that made epinephrine injection contraindicated.

All selected patients will randomly allocate to one of the two groups: group A will receive caudal epidural block (CEB) plus general anesthesia before surgery and group B will receive general anesthesia before surgery and CEB afterwards. The surgical procedures will be performed by a single pediatric urologist (FA). The surgical technique will be tubularized incised plate in all cases.

Intraoperative blood loss will be determined by weighing all surgical gauzes used during procedure with a digital scale measure to the nearest 0.01 gram, every 10 minutes to minimize the effect of water vaporization on gauzes weights.

In addition to blood loss, operation time, dose of fentanyl used during procedure and length of the urethral plate defect will be recorded for each patient by trained nurses.

Demographics and disease characteristics as well as operation details will be compared in the two studied groups.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bupivacaine
  • Procedure: General anesthesia
  • Drug: Dilute epinephrine injection
  • Drug: Fentanyl
  • Drug: dextrose plus sodium chloride.
  • Drug: neostigmine and atropine
  • Procedure: Hypospadias repair
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair; A Randomized Clinical Trial
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: General anesthesia + caudal block

Patients who receive general anesthesia plus caudal epidural block and dilute epinephrine injection before hypospadias repair, intraoperative fentanyl, intraoperative intravenous fluid and reversing the muscle relaxants' effect at the end of operation

Drug: Bupivacaine
Injection of Bupivacaine in the epidural space (0.25%, 0.33mg/Kg)
Other Names:
  • Caudal block
  • Drug: Dilute epinephrine injection
    Injection of 1/100000 epinephrine solution along all incision lines

    Drug: Fentanyl
    fentanyl 2 mcg /Kg that is repeated during surgery whenever the heart rate or blood pressure increased more than 20% of its baseline

    Drug: dextrose plus sodium chloride.
    Four mL/Kg/hr of 5% dextrose plus 0.04 mL/Kg/hr of 20% sodium chloride. Each mL of blood loss was replaced by 3 ml of Ringer's solution

    Drug: neostigmine and atropine
    Injection of 0.04 mg/Kg of neostigmine and 0.02 mg/Kg of atropine, intravenously at the end of operation.

    Procedure: Hypospadias repair
    Surgical repair of hypospadias, using tubularized incised plate technique

    Active Comparator: General anesthesia only

    Patients who receive only general anesthesia and dilute epinephrine injection before hypospadias repair, intraoperative fentanyl, intraoperative intravenous fluid and reversing the muscle relaxants' effect at the end of operation

    Procedure: General anesthesia
    Induction with thiopental sodium 5 mg/Kg, atracurium 0.4 mg/Kg and fentanyl 2 mcg/Kg and maintenance with isoflurane and a combination of oxygen and nitrous oxide

    Drug: Dilute epinephrine injection
    Injection of 1/100000 epinephrine solution along all incision lines

    Drug: Fentanyl
    fentanyl 2 mcg /Kg that is repeated during surgery whenever the heart rate or blood pressure increased more than 20% of its baseline

    Drug: dextrose plus sodium chloride.
    Four mL/Kg/hr of 5% dextrose plus 0.04 mL/Kg/hr of 20% sodium chloride. Each mL of blood loss was replaced by 3 ml of Ringer's solution

    Drug: neostigmine and atropine
    Injection of 0.04 mg/Kg of neostigmine and 0.02 mg/Kg of atropine, intravenously at the end of operation.

    Procedure: Hypospadias repair
    Surgical repair of hypospadias, using tubularized incised plate technique

    Outcome Measures

    Primary Outcome Measures

    1. Intraoperative blood loss [During procedure]

      The amount of blood loss during the operation

    Secondary Outcome Measures

    1. Dose of fentanyl used [during the operation]

    2. operation time [during procedure]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 15 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    age between 6 months to 15 years and hypospadias with any severity

    Exclusion Criteria:

    coagulopathy, history of previous failed surgery, skin infection , parents' disagreement with the protocol and any cardiac problem that made epinephrine injection contraindicated

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Isfahan University of Medical Sciences

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Farshid Alizadeh, Associate Professor, Isfahan University of Medical Sciences
    ClinicalTrials.gov Identifier:
    NCT02752308
    Other Study ID Numbers:
    • 393854
    First Posted:
    Apr 26, 2016
    Last Update Posted:
    Apr 26, 2016
    Last Verified:
    Apr 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 26, 2016